World Of Taxonomy
0169-2081Level 3

Alhemo (concizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** CONCIZUMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Novo Nordisk

**Marketing category:** BLA (BLA761315)

**Pharmacologic class:** Tissue Factor Pathway Inhibitor Antagonist [EPC], Tissue Factor Pathway Inhibitor Antagonists [MoA]

GET/api/v1/systems/ndc_fda/nodes/0169-2081
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.